Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 869, pseudogene (RN7SL869P)

Target
RN7SL869P
Molecular classification
Other (Pseudogene, Non-coding RNA derivative)
01

Overview

RN7SL869P (RNA, 7SL, cytoplasmic 869, pseudogene) is a human pseudogene derived from the 7SL RNA gene, which normally encodes the RNA component of the signal recognition particle (SRP)[6][5][7]. Unlike functional genes, pseudogenes like RN7SL869P are nonfunctional DNA sequences that resemble their parent genes but have lost their protein-coding and/or functional RNA capacity due to mutational disablement[4][5]. Most 7SL-like sequences in the human genome are pseudogenes generated by retrotransposition or related mechanisms, and they do not produce active RNA or protein[5][7]. RN7SL869P is not considered a true biological target (it does not act as an enzyme, receptor, transporter, or similar therapeutic target)[6][4], does not have known biological functions, and has no established roles in disease, biomarker use, drug interactions, or therapeutic safety concerns. Note: - This entry does NOT represent a functional gene, biologically meaningful RNA, or drug target—rather, it is an inactive, noncoding pseudogene. - There is nothing misspelled or obviously incorrect, but as a pseudogene, it is of limited if any, biological or therapeutic interest[4][6][7]. - Pseudogenes can sometimes complicate genetic studies through sequence similarity (e.g., PCR bias) but are not targets for therapeutics or diagnostics[4].

Other names
RN7SL869P

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 869, pseudogene (RN7SL869P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 869, pseudogene (RN7SL869P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call